Stryker Corporation with price, financials, news flow, and insider context in one page.
Stryker Corporation is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where SYK sits inside Healthcare and Medical Devices, and the key financial markers that matter before moving into a fuller research workflow.
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
This page is structured for research context, not a trade call. It gives you a clean read on where SYK sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q1 2026 | 6.02B | 745M | 415M |
| Q4 2025 | 7.17B | 849M | 1.88B |
| Q3 2025 | 6.06B | 859M | 1.35B |
| Q2 2025 | 6.02B | 884M | 928M |
The attacks come as the United States and Iran are supposed to be engaging in a 60-day ceasefire as they attempt to work toward a resolution.
See the next report date, earnings cadence, and reporting context.
Open a side-by-side comparison page to frame valuation and growth.
Read open desk notes tied to sectors, macro themes, and active names.
Learn the framework behind valuation, momentum, and risk before you act.
Stryker Corporation (SYK) — questions investors ask
What is the current stock price of Stryker Corporation (SYK)?
Stryker Corporation (SYK) is trading at $332.71, up 5.25% in the latest session. The live price and one-year chart on this page update through the trading day.
What is Stryker Corporation's market capitalization?
Stryker Corporation has a market capitalization of about 127.55B, derived from the latest share price and shares outstanding.
When is Stryker Corporation's next earnings date?
Stryker Corporation is next expected to report earnings on Jul 30, 2026. The SYK earnings page tracks the estimate and reporting history.
What is Stryker Corporation's P/E ratio?
Stryker Corporation trades at a forward price-to-earnings ratio of 19.89 — one measure of how the market is pricing its future earnings.
What is SYK's 52-week trading range?
Over the past 52 weeks, SYK has traded between $281.00 and $404.87.
What sector is Stryker Corporation in?
Stryker Corporation operates in the Healthcare sector, within the Medical Devices industry.
Does Stryker Corporation pay a dividend?
Stryker Corporation currently carries a dividend yield of about 100.0%.
What is the analyst price target for SYK?
The mean analyst price target for SYK is $386.80, with an overall analyst view of Buy.
A public stock page should answer the first research questions before asking for a signup.
This SYK page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.